Safety and Efficacy of Lactobacillus Reuteri DSM 17938 to Reduce the Crying Time in Infants With Colic: Randomised Controlled Trial With Two Parallel Arms. Version 3.3. Nov,11th,2016
Latest Information Update: 21 Jul 2022
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Colic
- Focus Therapeutic Use
- 27 Jul 2019 Planned End Date changed from 30 Jan 2019 to 30 Jan 2020.
- 27 Jul 2019 Planned primary completion date changed from 15 Dec 2018 to 30 Nov 2019.
- 06 Dec 2017 New trial record